Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1952 1
1956 1
1957 1
1958 4
1959 3
1968 1
1970 1
1976 1
1978 2
1979 1
1980 1
1981 4
1982 4
1983 4
1984 10
1985 8
1986 6
1987 8
1988 6
1989 5
1990 13
1991 12
1992 8
1993 8
1994 8
1995 6
1996 12
1997 12
1998 7
1999 13
2000 18
2001 20
2002 13
2003 30
2004 24
2005 21
2006 17
2007 25
2008 29
2009 32
2010 36
2011 52
2012 46
2013 51
2014 40
2015 54
2016 56
2017 75
2018 82
2019 76
2020 118
2021 121
2022 110
2023 109
2024 88
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,348 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacology and Clinical Development of Factor XI Inhibitors.
Greco A, Laudani C, Spagnolo M, Agnello F, Faro DC, Finocchiaro S, Legnazzi M, Mauro MS, Mazzone PM, Occhipinti G, Rochira C, Scalia L, Capodanno D. Greco A, et al. Among authors: mauro ms. Circulation. 2023 Mar 14;147(11):897-913. doi: 10.1161/CIRCULATIONAHA.122.062353. Epub 2023 Mar 13. Circulation. 2023. PMID: 36913497 Review.
Complete Percutaneous Coronary Revascularization in Acute Coronary Syndromes With Multivessel Coronary Disease: A Systematic Review.
Faro DC, Laudani C, Agnello FG, Ammirabile N, Finocchiaro S, Legnazzi M, Mauro MS, Mazzone PM, Occhipinti G, Rochira C, Scalia L, Spagnolo M, Greco A, Capodanno D. Faro DC, et al. Among authors: mauro ms. JACC Cardiovasc Interv. 2023 Oct 9;16(19):2347-2364. doi: 10.1016/j.jcin.2023.07.043. JACC Cardiovasc Interv. 2023. PMID: 37821180 Free article. Review.
Management of Chronic Myeloid Leukemia in Children and Young Adults.
Ford M, Mauro M, Aftandilian C, Sakamoto KM, Hijiya N. Ford M, et al. Among authors: mauro m. Curr Hematol Malig Rep. 2022 Oct;17(5):121-126. doi: 10.1007/s11899-022-00673-5. Epub 2022 Aug 3. Curr Hematol Malig Rep. 2022. PMID: 35920965 Free PMC article. Review.
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results.
Mauro MJ, Hughes TP, Kim DW, Rea D, Cortes JE, Hochhaus A, Sasaki K, Breccia M, Talpaz M, Ottmann O, Minami H, Goh YT, DeAngelo DJ, Heinrich MC, Gómez-García de Soria V, le Coutre P, Mahon FX, Janssen JJWM, Deininger M, Shanmuganathan N, Geyer MB, Cacciatore S, Polydoros F, Agrawal N, Hoch M, Lang F. Mauro MJ, et al. Leukemia. 2023 May;37(5):1048-1059. doi: 10.1038/s41375-023-01860-w. Epub 2023 Mar 22. Leukemia. 2023. PMID: 36949155 Free PMC article. Clinical Trial.
Ponatinib after failure of second-generation tyrosine kinase inhibitor in resistant chronic-phase chronic myeloid leukemia.
Kantarjian HM, Jabbour E, Deininger M, Abruzzese E, Apperley J, Cortes J, Chuah C, DeAngelo DJ, DiPersio J, Hochhaus A, Lipton J, Nicolini FE, Pinilla-Ibarz J, Rea D, Rosti G, Rousselot P, Shah NP, Talpaz M, Srivastava S, Ren X, Mauro M. Kantarjian HM, et al. Among authors: mauro m. Am J Hematol. 2022 Nov;97(11):1419-1426. doi: 10.1002/ajh.26686. Epub 2022 Aug 30. Am J Hematol. 2022. PMID: 36054756 Free PMC article.
Penile length and circumference dimensions: A large study in young Italian men.
Di Mauro M, Tonioni C, Cocci A, Kluth LA, Russo GI, Gomez Rivas J, Cacciamani G, Cito G, Morelli G, Polloni G, di Maida F, Giunti D; Trauma, Reconstructive Urology, Men’s Health Working Parties of the European Association of Urology (EAU) Young Academic Urologists (YAU). Di Mauro M, et al. Andrologia. 2021 Jul;53(6):e14053. doi: 10.1111/and.14053. Epub 2021 Mar 21. Andrologia. 2021. PMID: 33748967 Free PMC article.
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
Cortes JE, Gambacorti-Passerini C, Deininger MW, Mauro MJ, Chuah C, Kim DW, Dyagil I, Glushko N, Milojkovic D, le Coutre P, Garcia-Gutierrez V, Reilly L, Jeynes-Ellis A, Leip E, Bardy-Bouxin N, Hochhaus A, Brümmendorf TH. Cortes JE, et al. Among authors: mauro mj. J Clin Oncol. 2018 Jan 20;36(3):231-237. doi: 10.1200/JCO.2017.74.7162. Epub 2017 Nov 1. J Clin Oncol. 2018. PMID: 29091516 Free PMC article. Clinical Trial.
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial.
Brümmendorf TH, Cortes JE, Milojkovic D, Gambacorti-Passerini C, Clark RE, le Coutre P, Garcia-Gutierrez V, Chuah C, Kota V, Lipton JH, Rousselot P, Mauro MJ, Hochhaus A, Hurtado Monroy R, Leip E, Purcell S, Yver A, Viqueira A, Deininger MW; BFORE study investigators. Brümmendorf TH, et al. Among authors: mauro mj. Leukemia. 2022 Jul;36(7):1825-1833. doi: 10.1038/s41375-022-01589-y. Epub 2022 May 28. Leukemia. 2022. PMID: 35643868 Free PMC article. Clinical Trial.
Commentary: Better late than never!
Calafiore AM, Di Mauro M. Calafiore AM, et al. Among authors: di mauro m. J Thorac Cardiovasc Surg. 2019 Aug;158(2):438-439. doi: 10.1016/j.jtcvs.2018.10.095. Epub 2018 Oct 28. J Thorac Cardiovasc Surg. 2019. PMID: 30501944 Free article. No abstract available.
1,348 results